Identification and characterization of Cardiac Glycosides as senolytic compounds
Senolytic compounds have the ability to eliminate senescent cells from tissues and have been shown to be beneficial in various animal models of age-related diseases. Here the authors show that cardiac glycosides commonly used for heart diseases have senolytic properties in humanized mouse models of...
Guardado en:
Autores principales: | Francisco Triana-Martínez, Pilar Picallos-Rabina, Sabela Da Silva-Álvarez, Federico Pietrocola, Susana Llanos, Verónica Rodilla, Enrica Soprano, Pablo Pedrosa, Alba Ferreirós, Marta Barradas, Fernanda Hernández-González, Marta Lalinde, Neus Prats, Cristina Bernadó, Patricia González, María Gómez, Maria P. Ikonomopoulou, Pablo J. Fernández-Marcos, Tomás García-Caballero, Pablo del Pino, Joaquín Arribas, Anxo Vidal, Miguel González-Barcia, Manuel Serrano, María I. Loza, Eduardo Domínguez, Manuel Collado |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76f6dda146f1406681b8658e9fa1302e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Francisco Triana-Martínez, et al.
Publicado: (2020) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021) -
Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Alexandra Maximova, et al.
Publicado: (2021) -
Evaluating the neuroprotective impact of senolytic drugs on human vision
por: Nevin W. El-Nimri, et al.
Publicado: (2020) -
Identification of HSP90 inhibitors as a novel class of senolytics
por: Heike Fuhrmann-Stroissnigg, et al.
Publicado: (2017)